XORTX Highlights New Studies of Acute Kidney Disease Due to COVID-19 Infection

NEXT STORY
Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020
PREV STORY
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2018 Financial Results

Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday, November ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release September 26, 2017 at 10:00 AM EET Conversion of ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Preliminary 58-Week Results from Open-Label Extension of Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism Demonstrated Durable Benefit and a Well-Tolerated Safety Profile

author_avatar
NASDAQ Market News